Senel S - Search Results

1

Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1).

Günbeyaz M, Faraji A, Ozkul A, Puralı N, Senel S. Günbeyaz M, et al. Among authors: senel s. Eur J Pharm Sci. 2010 Nov 20;41(3-4):531-45. doi: 10.1016/j.ejps.2010.08.011. Epub 2010 Aug 26. Eur J Pharm Sci. 2010. PMID: 20800678

2

Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.

Senel S, Ikinci G, Kaş S, Yousefi-Rad A, Sargon MF, Hincal AA. Senel S, et al. Int J Pharm. 2000 Jan 5;193(2):197-203. doi: 10.1016/s0378-5173(99)00334-8. Int J Pharm. 2000. PMID: 10606782

3

Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis.

Ikinci G, Senel S, Akincibay H, Kaş S, Erciş S, Wilson CG, Hincal AA. Ikinci G, et al. Among authors: senel s. Int J Pharm. 2002 Mar 20;235(1-2):121-7. doi: 10.1016/s0378-5173(01)00974-7. Int J Pharm. 2002. PMID: 11879747

4

Potential applications of chitosan in veterinary medicine.

Senel S, McClure SJ. Senel S, et al. Adv Drug Deliv Rev. 2004 Jun 23;56(10):1467-80. doi: 10.1016/j.addr.2004.02.007. Adv Drug Deliv Rev. 2004. PMID: 15191793 Review.

5

Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.

Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. Aksungur P, et al. Among authors: senel s. J Control Release. 2004 Aug 11;98(2):269-79. doi: 10.1016/j.jconrel.2004.05.002. J Control Release. 2004. PMID: 15262418 Clinical Trial.

6

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S. Sayin B, et al. Among authors: senel s. Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9. Int J Pharm. 2008. PMID: 18662762

7

Chitosan-based systems for the delivery of vaccine antigens.

Arca HC, Günbeyaz M, Senel S. Arca HC, et al. Among authors: senel s. Expert Rev Vaccines. 2009 Jul;8(7):937-53. doi: 10.1586/erv.09.47. Expert Rev Vaccines. 2009. PMID: 19538118 Free article. Review.

8

TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.

Sayin B, Somavarapu S, Li XW, Sesardic D, Senel S, Alpar OH. Sayin B, et al. Among authors: senel s. Eur J Pharm Sci. 2009 Nov 5;38(4):362-9. doi: 10.1016/j.ejps.2009.08.010. Epub 2009 Sep 4. Eur J Pharm Sci. 2009. PMID: 19733658

9

Chitosan-based systems for intranasal immunization against foot-and-mouth disease.

Çokçalışkan C, Özyörük F, Gürsoy RN, Alkan M, Günbeyaz M, Arca HÇ, Uzunlu E, Şenel S. Çokçalışkan C, et al. Among authors: senel s. Pharm Dev Technol. 2014 Mar;19(2):181-8. doi: 10.3109/10837450.2013.763263. Epub 2013 Feb 4. Pharm Dev Technol. 2014. PMID: 23379822

10

Development and in vitro evaluation of chitosan based system for local delivery of atorvastatin for treatment of periodontitis.

Işılay Özdoğan A, Akca G, Şenel S. Işılay Özdoğan A, et al. Among authors: senel s. Eur J Pharm Sci. 2018 Nov 1;124:208-216. doi: 10.1016/j.ejps.2018.08.037. Epub 2018 Aug 29. Eur J Pharm Sci. 2018. PMID: 30171985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters